SEC Form 4 · accession 0001144204-15-008000
DERMA SCIENCES, INC. · DSCI
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Frederic Eigner
Officer — Executive VP - Operations
Period of report
Feb 9, 2015
Accepted (ET)
Feb 11, 2015 · 5:14 pm EST
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0000892160
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common Stock | Feb 9, 2015 | M | 15,235 | $4.00 | A | 58,533 | D | |
| Common StockF1 | Feb 9, 2015 | F | 6,909 | $8.82 | D | 51,624 | D |
Table II — derivative securities
| Security | Conv. / exercise price | Date | Code | Shares | A/D | Exercisable | Expires | Underlying | Underlying shares | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Stock Option (right to buy)F2 | $4.00 | Feb 9, 2015 | M | 15,235 | D | Mar 1, 2005 | Mar 1, 2015 | Common Stock | 15,235 | 0 | D |
Explanation of responses
- F1Shares delivered in connection with the cashless exercise of 15,235 options, previously granted pursuant to the issuer's stock option plan, at an exercise price of $4.00, as reported herein.
- F2The options were originally granted in consideration of the reporting person's services to the issuer and without payment of cash.